Purification process

Details for Australian Patent Application No. 2006218076 (hide)

Owner Novartis AG

Inventors Funfschilling, Peter; Beutler, Ulrich; Roth, Alfons; Penn, Gerhard

Agent Davies Collison Cave

Pub. Number AU-B-2006218076

PCT Pub. Number WO2006/089746

Priority 0503942.5 25.02.05 GB

Filing date 23 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 28 October 2010

International Classifications

C07C 209/84 (2006.01) Preparation of compounds containing amino groups bound to a carbon skeleton

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07C 211/30 (2006.01) Compounds containing amino groups bound to a carbon skeleton

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/089746 Priority application(s): WO2006/089746

28 October 2010 Application Accepted

  Published as AU-B-2006218076

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006218077-Pesticidal capsule formulation

2006218064-Dosing device for setting fine doses